IL286285A - Vista-binding antibodies and uses thereof - Google Patents

Vista-binding antibodies and uses thereof

Info

Publication number
IL286285A
IL286285A IL286285A IL28628521A IL286285A IL 286285 A IL286285 A IL 286285A IL 286285 A IL286285 A IL 286285A IL 28628521 A IL28628521 A IL 28628521A IL 286285 A IL286285 A IL 286285A
Authority
IL
Israel
Prior art keywords
vista
binding antibodies
antibodies
binding
Prior art date
Application number
IL286285A
Other languages
Hebrew (he)
Original Assignee
Xyence Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xyence Therapeutics Inc filed Critical Xyence Therapeutics Inc
Publication of IL286285A publication Critical patent/IL286285A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2827—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against B7 molecules, e.g. CD80, CD86
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL286285A 2019-03-12 2021-09-12 Vista-binding antibodies and uses thereof IL286285A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962817268P 2019-03-12 2019-03-12
PCT/US2020/022461 WO2020186098A1 (en) 2019-03-12 2020-03-12 Vista-binding antibodies and uses thereof

Publications (1)

Publication Number Publication Date
IL286285A true IL286285A (en) 2021-10-31

Family

ID=72428026

Family Applications (1)

Application Number Title Priority Date Filing Date
IL286285A IL286285A (en) 2019-03-12 2021-09-12 Vista-binding antibodies and uses thereof

Country Status (5)

Country Link
EP (1) EP3976654A1 (en)
JP (1) JP2022525261A (en)
CN (1) CN114729039A (en)
IL (1) IL286285A (en)
WO (1) WO2020186098A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105153307A (en) * 2010-05-04 2015-12-16 梅里麦克制药股份有限公司 Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
RU2732151C2 (en) * 2011-09-30 2020-09-11 Чугаи Сейяку Кабусики Кайся Library of concentration-dependent binding molecules
CN108025068A (en) * 2014-03-12 2018-05-11 耶达研究与开发有限公司 Reducing the level or activity of systemic regulatory T cells to treat CNS diseases and injuries
WO2016207717A1 (en) * 2015-06-24 2016-12-29 Janssen Pharmaceutica Nv Anti-vista antibodies and fragments
WO2017175058A1 (en) * 2016-04-07 2017-10-12 Janssen Pharmaceutica Nv Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
EP3494141A4 (en) * 2016-08-03 2020-04-08 Bio-Techne Corporation IDENTIFICATION OF VSIG3 / VISTA AS A NEW IMMUNE CONTROL POINT AND ITS USE IN IMMUNOTHERAPY

Also Published As

Publication number Publication date
JP2022525261A (en) 2022-05-11
CN114729039A (en) 2022-07-08
EP3976654A1 (en) 2022-04-06
WO2020186098A1 (en) 2020-09-17

Similar Documents

Publication Publication Date Title
IL282968A (en) Anti-nkg2a antibodies and uses thereof
IL276950A (en) Anti-cd73 antibodies and uses thereof
SG11202105885WA (en) Anti-claudin antibodies and uses thereof
IL275737A (en) Antibodies and variants thereof against tigit
IL289585A (en) Dll3-targeting antibodies and uses thereof
IL275826A (en) Anti-mct1 antibodies and uses thereof
ZA202006066B (en) Anti-hla-g antibodies and use thereof
SG11202104240TA (en) Cll1-targeting antibody and application thereof
IL278466B1 (en) Anti-dll3 antibodies and uses thereof
IL291027A (en) Anti-steap1 antibodies and uses thereof
IL280321A (en) Anti-cxcr2 antibodies and uses thereof
IL281202A (en) Anti-tnfrsf9 antibodies and uses thereof
ZA202100714B (en) Anti-npr1 antibodies and uses thereof
IL277075A (en) Anti-phf-tau antibodies and uses thereof
SG11202009625WA (en) Anti-trem-1 antibodies and uses thereof
IL289656A (en) Anti-tigit antibodies and application thereof
SG11202105161YA (en) Anti-il-27 antibodies and uses thereof
IL277330A (en) Anti-il-27 antibodies and uses thereof
IL276548A (en) Bcma-binding antibodies and uses thereof
SG11202012680TA (en) Anti-l1cam antibodies and uses thereof
IL283890A (en) Anti-periostin antibodies and uses thereof
ZA202210284B (en) Anti-trem1 antibodies and related methods
GB201902590D0 (en) Antibodies and uses thereof
IL288807A (en) Anti-talen antibodies and uses thereof
IL286285A (en) Vista-binding antibodies and uses thereof